Track the Cibus, Inc. share price and the full insider trade history of the company, a publicly traded company based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €135.3m. The latest transaction was disclosed on 10 June 2026 (Attribution). Among the most active insiders: Prante Gerhard. The full history is free.
108
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€238,880
56 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Cibus, Inc. Buy (bullish), based on 3 analysts. Average price target: US$14.33.
30Σ signal
Buys n/a€238,880 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
11,750 shares0Class A Common StockSEC:0001615594-25-000051:0
25 of 108 declarations
Acerca de Cibus, Inc.
Cibus, Inc. es una empresa de biotecnología centrada en el desarrollo de soluciones para la agricultura. Se especializa en la mejora de cultivos mediante métodos innovadores.